Rituximab Treatment for Psychosis And/or Obsessive Compulsive Disorder with Probable Immune System Involvement

Clinical trial NCT04323566 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT04323566
Sponsor: Uppsala University Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 2
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder Obsessive-Compulsive Behavior Schizophrenia Delusional Disorder Brief Psychotic Disorder Schizo Affective Disorder Other Psychoses Unspecified Psychosis

Start date: 2022-05-01
Primary completion: 2028-04-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.